BioUtah News
-
Biomerics Announces Expansion in Costa Rica With New Plant in Cartago
Biomerics inaugurated its second plant in Costa Rica.
-
GPX Embolic Device Success in Challenging Tumor Case
Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors
-
Foldax Appoints Scott Huennekens to Board of Directors
Foldax Appoints Scott Huennekens to Board of Directors
-
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication
PolarityTE, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND)…
-
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test
Co-Diagnostics, Inc. announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (“CDSCO”)…
-
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
-
Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy
Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy
-
CenExel Clinical Research Acquires Rocky Mountain Movement Disorders Center
Premier Neurology Facility in Colorado Joins the CenExel Centers of Excellence
-
CenExel Clinical Research Acquires California Neuroscience Research
CenExel Clinical Research, Inc. announced the acquisition of California Neuroscience Research.
-
Nexus Spine Appoints David Ivanko as Vice President of Quality Engineering and Manufacturing and Andrew Shepherd as Vice President of Marketing
Nexus Spine announced key appointments to its leadership team that includes David Ivanko as Vice President of Quality…
-
Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast
Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved populations with high disease burden
-
BlueWind Medical™ Ltd. Makes Key Additions to Leadership Team
PARK CITY, Utah and HERZLIYA, Israel, Jan. 6, 2022 /PRNewswire/ — BlueWind Medical™, Ltd., developer of the innovative RENOVA™…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
